Chuck Farkas

Track

Insider profile

Currently holds a position at Conmed Corp

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Conmed Corp July 23, 2014 -
Chuck Farkas's trades of Conmed Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-15 2025-09-12
US Conmed Corp (CNMD)
S Sale
27,167 -47.1%
182.51
US$3,003,500 		27,167 -47.1% 182.51 US$3,003,500
2025-09-15 2025-09-12
US Conmed Corp (CNMD)
S Sale
36,446 +45.1%
270.29
US$2,972,996 		36,446 +45.1% 270.29 US$2,972,996
2025-09-12 2025-09-12
US Conmed Corp (CNMD)
PrS Proposed sale
9,062
447.34
US$99,373 		9,062 447.34 US$99,373
2025-05-06 2025-05-05
US Conmed Corp (CNMD)
S Sale
4,000 -19.7%
56.94
US$227,768 		4,000 -19.7% 56.94 US$227,768
2025-05-05 2025-05-05
US Conmed Corp (CNMD)
PrS Proposed sale
4,000
56.94
US$227,768 		4,000 56.94 US$227,768
2016-10-04 2016-10-03
US Conmed Corp (CNMD)
PP Planned purchase
336 +4.4%
40.04
US$13,453 		336 +4.4% 40.04 US$13,453
2016-07-05 2016-07-01
US Conmed Corp (CNMD)
PP Planned purchase
282 +3.8%
47.87
US$13,499 		282 +3.8% 47.87 US$13,499